SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-021736
Filing Date
2018-08-08
Accepted
2018-08-08 18:30:36
Documents
2
Period of Report
2018-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1656
2 EX-24 DOCUMENT attachment1.htm EX-24 2553
  Complete submission text file 0000899243-18-021736.txt   5757
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address
Litton Mark James (Reporting) CIK: 0001604834 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 181002788

Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations